Shanghai Fosun Pharma gets conditional NMPA approval for GR1803
Shanghai Fosun Pharma received marketing registration approval with conditions for GR1803 from the NMPA.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.